4 completed, 1 terminated. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Terminated 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Arrow Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of AZD7295 Capsules AZD7295, Placebo comparator - Healthy | Phase 1 | Completed | Arrow Therapeutics | 12 | 2010-03-01 | 2010-08-09 |
| Clinical Pharmacology Study of AZD7295 in Healthy Subjects AZD7295, Placebo - Healthy | Phase 1 | Completed | Arrow Therapeutics | 16 | 2009-04-01 | 2010-02-12 |
| Antiviral Activity of AZD7295 in HCV Carriers AZD7295, Placebo - Hepatitis C | Phase 1 | Completed | Arrow Therapeutics | 31 | 2008-11-01 | 2010-03-31 |
| A Study of the PK, Safety and Antiviral Activity of A-831 in HCV Carriers A-831 - Chronic Hepatitis C | Phase 1 / Phase 2 | Terminated | Arrow Therapeutics | 36 | 2007-08-01 | 2008-09-29 |
| A Study of the Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT A-60444 - Respiratory Syncytial Virus Infections | Phase 2 | Completed | Arrow Therapeutics | 27 | 2005-09-01 | 2010-02-12 |
Hepatitis C (2) · Hepatitis C, Chronic (1) · Respiratory Syncytial Virus Infections (1)
United Kingdom (4) · New Zealand (2)
Brian Sanderson (1) · David Mutimer (1) · Ed Gane (1) · Edward Gane (1) · Jo Collier, Mb ChB (1) · Stephen MacKinnon (1)